Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Sanofi image

Sanofi sees FDA approval for diabetes drug

February 26, 2015
Sales and Marketing Afrezza, FDA, Q2, Sanofi, Twitter, diabetes, insulin glargine, q4

US regulators have approved Sanofi’s diabetes treatment Toujeo which is said to be a follow-up to the French firms key …

News
Merck image

Merck invests $450m in NGM Biopharma

February 23, 2015
Sales and Marketing Merck, NGM Biopharma, NP201, diabetes, nonalcoholic steatohepatitis, obesity

Merck is to collaborate on drug development with biotech firm NGM Pharmaceuticals in a $450 million deal. The collaboration will …

News
Sanofi image

Sanofi sales lifted by diabetes and rare diseases

February 6, 2015
Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4

Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …

News
AZ image

AstraZeneca looks for revenue boost via Actavis buy

February 6, 2015
Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4

AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …

News
affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

News
Tattoo image

Needle-free device shows potential in diabetes

January 23, 2015
Medical Communications, Sales and Marketing Cygnus, University of California, diabetes, tattoo

A ‘tattoo-like’ ultra-thin sensor that sits on the skin has been developed that could help patients monitor their blood glucose …

News
VBLOC image

FDA approves novel obesity device

January 16, 2015
Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2

The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …

News
BI image

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015
Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

News
Novo image

Novo Nordisk obesity drug gets FDA nod

December 24, 2014
Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda

The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …

News

NICE changes insulin advice in diabetes guidelines

December 12, 2014
Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2

NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …

News
Roche image

Roche buys Ariosa Diagnostics

December 2, 2014
Research and Development, Sales and Marketing IPF, IQuum, InterMune, Roche, ariosa, cfdna, diabetes, genia, seragon

Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into …

News
AZ image

AstraZeneca diabetes drug approved for use in Scotland

November 11, 2014
Sales and Marketing Afinitor, AstraZeneca, Eylea, Onglyza, Perjeta, SMC, diabetes, type 2

The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …

News

Novo Nordisk to open $130 million diabetes labs

November 3, 2014
Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes

Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …

News
Actos image

Takeda and Lilly get Actos trial reprieve

October 29, 2014
Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly

A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …

News
Victoza image

FDA panel backs liraglutide for obesity

September 12, 2014
Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity

An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026